ALEMBIC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALEMBIC, and what generic and branded alternatives to ALEMBIC drugs are available?
ALEMBIC has one hundred and seventy-two approved drugs.
There are ten tentative approvals on ALEMBIC drugs.
Summary for ALEMBIC
US Patents: | 0 |
Tradenames: | 134 |
Ingredients: | 133 |
NDAs: | 172 |
Patent Litigation for ALEMBIC: | See patent lawsuits for ALEMBIC |
PTAB Cases with ALEMBIC as petitioner: | See PTAB cases with ALEMBIC as petitioner |
Drugs and US Patents for ALEMBIC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alembic | LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 213248-003 | May 13, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Alembic Pharms Ltd | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | CAPSULE;ORAL | 090223-002 | Mar 19, 2009 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Alembic | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 090430-002 | Oct 27, 2010 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.